2m 2m 2m 2m 2m 2m 2m
Dexcom (DXCM)
NASDAQ
$92.19-$0.15 (-0.16%)
Price as of Aug 21, 2026 7:56 PM EDT- $34.8BMarket Cap
- 12.25%1-Year Change
- Medical DevicesIndustry
Dexcom (DXCM)
$92.19-$0.15 (-0.16%)
DXCM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $92.34 | ||
Change | +$2.12 (+2.35%) | ||
Open | $89.61 | ||
High | $92.56 | ||
Low | $89.20 | ||
Previous Close | $90.22 | ||
Volume | 3,481,761 | ||
30-Day Average Volume | 5,448,305 | ||
1-Week Change | 2.89% | ||
1-Month Change | 23.53% | ||
1-Year Change | 12.25% | ||
3-Year Change | -11.79% | ||
5-Year Change | -28.83% | ||
Fundamentals | |||
Shares Outstanding | 377.4M | ||
Total Assets | $6.5B | ||
Market Cap | $34.8B | ||
Enterprise Value | $35.0B | ||
Period: QTR TTM FY | |||
Revenue | $1.3B | ||
Net Income | $249.1M | ||
Free Cash Flow | $184.5M | ||
EBIT | $319.7M | ||
EBITDA | $387.9M | ||
Net Working Capital | $1.7B | ||
EPS | $0.64 | ||
Enterprise Value/EBITDA | 90 | ||
Enterprise Value/Revenue | 27 | ||
P/B | 13 | ||
P/E | 144 | ||
PEG | 6 | ||
Price/Free Cash Flow | 189 | ||
Price/Operating Cash Flow | 129 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 4 : 1 | ||
Last Split Date | 06/13/2022 | ||
Earnings & Revenue